AllAnalyst Report
logoMorningstarSeptember 04, 2020

The Cooper Companies, Inc.: Cooper Reports Weak but Improving Q3 Earnings; COVID-19 Impact Clouds Our Vision of Future Growth

Symbols
COO
Sector(s)
Healthcare
Rating
Premium
Current Price
$347.46
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE